Collegium Pharma (COLL) Misses Q4 EPS by $1.77

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. SWKS
8. SPY
9. XYZ
10. CVS

Go back to Collegium Pharma (COLL) Misses Q4 EPS by $1.77

Collegium Reports Fourth Quarter and Full-Year 2021 Financial Results

February 24, 2022 4:01 PM EST

BDSI Acquisition Expected to Close Late Q1 2022

2022 Revenue Guidance of $315-$330 Million, Growth Driven by Xtampza ER

Full-Year Net Income of $71.5 Million and Full-Year Adjusted EBITDA of $118.3 million

Cash Balance of $186.4 Million

Conference Call Scheduled for Today at 4:30 p.m. ET

STOUGHTON, Mass., Feb. 24, 2022 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc.... More